Meta-analysis of odds ratios for the COMT Gene rs737865 SNP for schizophrenia

Gulden Hakverdi; Harika Gözükara Bağ

doi:10.7197/cmj.1606628

TR EN

Şizofreni için COMT Geni rs737865 SNP odds oranlarının meta analizi

Öz

Özet Amaç: İlgilenilen konuda yapılan birden çok bağımsız çalışmanın bulgularını uygun istatistiksel metotlarla birleştirmeyi sağlayan metotlar topluluğuna meta analizi adı verilir. Şizofreni, birçok çevresel ve genetik faktörle bağlantılı karmaşık bir psikiyatrik hastalıktır ve dünya nüfusunun %1'ini etkilemektedir. Katekol-O-Metiltransferaz (COMT) geni şizofreniye yatkınlık için aday bir gen olarak görülmektedir. Bu çalışmada, şizofreni için COMT geninin rs737865 SNP’ne (tek nükleotit polimorfizmi) göre farklı çalışmalardan elde edilen odds oranlarının meta analizi ile birleştirilmesi amaçlanmıştır. Materyal ve Metot: Yazım dili İngilizce olan yayınlar "COMT ve şizofreni" anahtar kelimeleri ile Ekim 2024 tarihine kadar Web of Science, Pubmed ve Google Akademik veri tabanlarında ile taranmıştır. Dâhil olma kriterlerini sağlayan 17 çalışma ve ayrıca ırka göre Asyalı ve Beyaz ırklar için sırasıyla 8 ve 4 çalışma için farklı genetik modeller altında, uygun meta analitik yöntemler yardımıyla ortak odds oranı kestirimleri elde edillmiştir. Tüm analizlerde STATA 14.0 programı kullanılmıştır. Bulgular: On yedi çalışmaya uygulanan farklı genetik modeller altında, sadece CC genotipine sahip olanların T (TT+CT) alleli taşıyıcılarına göre şizofreni için risk taşıdığı bulunmuştur [OR=1,133 (%95 G.A.=1,008 – 1,273)]. Irka göre yapılan alt grup analizlerinde ise Asyalı ırk için bir riskten söz edemezken Beyaz ırk için C (CC+CT) alleli taşıyıcılarının TT genotipine sahip olanlara göre şizofreni riskini arttırdığı bulunmuştur [OR=1,586 (%95 G.A.=1,349 – 1,865)]. Sonuç: Uygulanan meta-analitik yöntemler yardımıyla bağımsız çalışmalardan elde edilen odds oranları (OR) için farklı genetik modeller altında tümel kestirimler elde edilmiştir. Bununla birlikte, etnik köken açısından homojen daha büyük gruplarda yapılan çalışmalar ile COMT geni rs737865 SNP’i ile şizofreni arasındaki bağın incelenmesi gerektiği düşünülmektedir.

Anahtar Kelimeler

Meta-analysis of odds ratios for the COMT Gene rs737865 SNP for schizophrenia

Abstract

ABSTRACT Meta-analysis of COMT Gene rs737865 SNP odds ratios for schizophrenia Background: The collection of methods that enable combining the findings of several independent studies on the topic of interest with appropriate statistical methods is called meta-analysis. Schizophrenia is a complex psychiatric disease linked to many environmental and genetic factors and affects up to 1% of the world's population. A candidate gene for schizophrenia susceptibility is the catechol-O-methyltransferase (COMT) gene. This study aimed to combine the odds ratios obtained from different studies according to the rs737865 SNP (single nucleotide polymorphism) of the COMT gene for schizophrenia by meta-analysis. Material and Method: Publications written in English were scanned with the keywords "COMT and schizophrenia" in Web of Science, Pubmed, and Google Scholar databases until October 2024. Common odds ratio estimates were obtained with the help of appropriate meta-analytic methods under different genetic models for 17 studies that met the inclusion criteria, as well as 8 and 4 studies for Asians and Caucasians, respectively, by race. STATA 14 program was used for all analyses. Results: Under different genetic models applied to seventeen studies, only carriers of the CC genotype were found to have a higher risk for schizophrenia than carriers of the T (TT+CT) allele [OR=1.133 (95% CI=1.008 - 1.273)]. In subgroup analyses according to race, no risk was found for Asians. In contrast, for Caucasians, it was found that carriers of the C (CC+CT) allele had an increased risk of schizophrenia compared to those with TT genotype [OR=1.586 (95% CI=1.349 - 1.865)]. Conclusion: With the help of applied meta-analytic methods, overall estimates were obtained for odds ratios (OR) obtained from independent studies under different genetic models. However, it is thought that the association between COMT gene rs737865 SNP and schizophrenia should be examined with studies conducted in larger groups homogeneous in terms of ethnicity. Keywords: Meta-analysis, COMT, odds ratio, schizophrenia.

Keywords

Destekleyen Kurum

İnönü Üniversitesi Bilimsel Araştırma Projeleri (BAP) birimi

Proje Numarası

BAP 2016/149

Etik Beyan

Yüksek lisans tezimin makalesi olup, meta analiz çalışması olduğundan ve açık erişimli çalışmalar dahil edildiğinden dolayı etik kurul belgesi gerekmemektedir.

Teşekkür

İnönü Üniversitesi Bilimsel Araştırma Projeleri (BAP) birimi

Kaynakça

1. Wilson DB, Lipsey MW. The role of method in treatment effectiveness research: Evidence from meta-analysis. Psychological Methods. 2001;6(4):413-429. doi:https://doi.org/10.1037/1082-989x.6.4.413
2. Schulze R. The State and the Art of Meta-Analysis. Zeitschrift für Psychologie / Journal of Psychology. 2007;215(2):87-89. doi:https://doi.org/10.1027/0044-3409.215.2.87
3. Rothman KJ, Sander Greenland, Lash TL. Modern Epidemiology. Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008.
4. Shifman S, Bronstein M, Sternfeld M, et al. A Highly Significant Association between a COMT Haplotype and Schizophrenia. The American Journal of Human Genetics. 2002;71(6):1296-1302. doi:https://doi.org/10.1086/344514
5. Nunokawa A, Watanabe Y, Tatsuyuki Muratake, Kaneko N, Koizumi M, Toshiyuki Someya. No associations exist between five functional polymorphisms in the catechol-O-methyltransferase gene and schizophrenia in a Japanese population. Neuroscience Research. 2007;58(3):291-296. doi:https://doi.org/10.1016/j.neures.2007.03.015
6. Galen E.B. Wright, Dana J.H. Niehaus, van, et al. Association of MB-COMT polymorphisms with schizophrenia-susceptibility and symptom severity in an African cohort. Progress in Neuro-psychopharmacology & Biological Psychiatry. 2012;39(1):163-169. doi:https://doi.org/10.1016/j.pnpbp.2012.06.006
7. Martorell L, Costas J, Valero J, et al. Analyses of variants located in estrogen metabolism genes (ESR1, ESR2, COMT and APOE) and schizophrenia. Schizophrenia Research. 2008;100(1-3):308-315. doi:https://doi.org/10.1016/j.schres.2007.11.001
8. Lee SG, Yeon Ho Joo, Kim BS, et al. Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans. Hum Genet. 2005;116(4):319-328. doi:https://doi.org/10.1007/s00439-004-1239-y

9. Funke B, Malhotra AK, Finn CT, et al. COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behavioral and brain functions: BBF. 2005;18:1-19. doi: https://doi.org/10.1186/1744-9081-1-19
10. Chen CY ., Lu RB ., Yeh YW ., Shih MC ., Huang SY . Association study of catechol-O-methyltransferase gene polymorphisms with schizophrenia and psychopathological symptoms in Han Chinese. Genes, Brain and Behavior. 2011;10(3):316-324. doi:https://doi.org/10.1111/j.1601-183x.2010.00670.x
11. Higashiyama R, Ohnuma T, Takebayashi Y, et al. Association of copy number polymorphisms at the promoter and translated region of COMT with Japanese patients with schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2016;171(3):447-457. doi:https://doi.org/10.1002/ajmg.b.32426
12. Yu R, Zhang X, Huang X, Ding S, Li J. Association analysis of COMT polymorphisms and schizophrenia in a Chinese Han population: A case‐control study. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2007;144B(4):570-573. doi:https://doi.org/10.1002/ajmg.b.30487
13. Maria K, Charalampos T, Vassilakopoulou D, Stavroula S, Vasiliki K, Nikolaos D. Frequency Distribution of COMT Polymorphisms in Greek Patients with Schizophrenia and Controls: A Study of SNPs rs737865, rs4680, and rs165599. ISRN Psychiatry. 2012;2012:1-6. doi:https://doi.org/10.5402/2012/651613
14. Acar C, Sözen MM, Gözükara H, Orman K, Kartalcı Ş. Lack of association between catechol-Omethyltransferase and schizophrenia in a Turkish population. Turkish Journal of Biochemistry. 2015;40(3). doi:https://doi.org/10.1515/tjb-2015-0002
15. Talkowski ME, Kirov G, Bamne M, et al. A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Human Molecular Genetics. 2007;17(5):747-758. doi:https://doi.org/10.1093/hmg/ddm347
16. Okochi T, Ikeda M, Kishi T, et al. Meta-analysis of association between genetic variants in COMT and schizophrenia: An update. Schizophrenia Research. 2009;110(1-3):140-148. doi:https://doi.org/10.1016/j.schres.2009.02.019
17. Dean B, Scarr E. COMT genotype is associated with differential expression of muscarinic M1 receptors in human cortex. American journal of medical genetics Part B, Neuropsychiatric genetics. 2016;171(6):784-789. doi:https://doi.org/10.1002/ajmg.b.32440
18. Chien YL, Liu CM, Fann CSJ, Liu YL, Hwu HG. Association of the 3′ Region of COMT with Schizophrenia in Taiwan. Journal of the Formosan Medical Association. 2009;108(4):301-309. doi:https://doi.org/10.1016/s0929-6646(09)60070-x
19. Park BL, Shin HD, Cheong HS, et al. Association analysis of COMT polymorphisms with schizophrenia and smooth pursuit eye movement abnormality. Journal of Human Genetics. 2009;54(12):709-712. doi:https://doi.org/10.1038/jhg.2009.102
20. Gupta M, Bhatnagar P, Grover S, et al. Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment. Pharmacogenomics. 2009;10(3):385-397. doi:https://doi.org/10.2217/14622416.10.3.385
21. Handoko HY, Nyholt DR, Hayward NK, et al. Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia. Molecular Psychiatry. 2004;10(6):589-597. doi:https://doi.org/10.1038/sj.mp.4001606
22. Salisbury BA, Pungliya M, Choi JY, Jiang R, Sun XJ, Stephens JClaiborne. SNP and haplotype variation in the human genome. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 2003;526(1-2):53-61. doi:https://doi.org/10.1016/s0027-5107(03)00014-9
23. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Systematic Reviews. 2021;10(1). https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-021-01626-4
24. Matsuzaka CT, Christofolini D, Ota VK, et al. Catechol-O-methyltransferase (COMT) polymorphisms modulate working memory in individuals with schizophrenia and healthy controls. Brazilian Journal of Psychiatry. 2017;39(4):302-308. doi:https://doi.org/10.1590/1516-4446-2016-1987
25. Agresti A. Categorical Data Analysis. John Wiley & Sons; 2013.
26. Alpar R. Uygulamalı Çok Değişkenli Istatistiksel Yöntemler. 3rd ed. Detay Yayıncılık; 2013.
27. Gozukara Bag HG. Association between COMT gene rs165599 SNP and schizophrenia: A meta-analysis of case-control studies. Molecular Genetics & Genomic Medicine. 2018;6(5):845-854. doi:https://doi.org/10.1002/mgg3.468
28. Lau J, Ioannidis JP, Schmid C. Quantitative Synthesis in Systematic Reviews. Annals of Internal Medicine. 1997;127(9):820. doi:https://doi.org/10.7326/0003-4819-127-9-199711010-00008
29. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560. doi:https://doi.org/10.1136/bmj.327.7414.557
30. Mukherjee N, Kidd KK, Pakstis AJ, et al. The complex global pattern of genetic variation and linkage disequilibrium at catechol- O -methyltransferase. Molecular Psychiatry. 2010;15(2):216-225. doi:https://doi.org/10.1038/mp.2008.64

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Bilişimi ve Bilişim Sistemleri , Uygulama Bilimi ve Değerlendirme

Bölüm

Sistematik Derlemeler ve Meta Analiz

Yazarlar

Gulden Hakverdi ^*
0000-0002-8078-0451
Türkiye

Harika Gözükara Bağ
0000-0003-1208-4072
Türkiye

Yayımlanma Tarihi

31 Aralık 2024

Gönderilme Tarihi

24 Aralık 2024

Kabul Tarihi

28 Aralık 2024

Yayımlandığı Sayı

Yıl 2024 Cilt: 46 Sayı: 4

DOI

https://doi.org/10.7197/cmj.1606628

IZ

https://izlik.org/JA33YE64TC

Kaynak Göster

RIS / Bibtex

AMA

1.Hakverdi G, Gözükara Bağ H. Meta-analysis of odds ratios for the COMT Gene rs737865 SNP for schizophrenia. CMJ. 2024;46(4):300-307. doi:10.7197/cmj.1606628